Summary The status of assay for S-1 00 antigen protein and anticeramide antibodies in serum in understanding nerve damage in different forms of leprosy were evaluated by the enzyme immunoassay. Based on the clinical and smear examination, patients were classified as indeterminate (Ind), tuberculoid (IT), borderline tuberculoid (BT), borderline lepromatous (BL) and lepromatous (LL).
glycosphingolipids (ceramide, galactocerebroside, gangliosides and sulphatides) present in the nervous tissue are known to be immunogenic. Antibodies to total nerve lipids and galactocerebrosides have been demonstrated in the sera of leprosy patients.
? Patients suffering from Gullian-Barre syndrome and systemic lupus erythromatosis with peripheral neuropathy have elevated levels of antiglycosphingolipids. 8 In an experimental study on Mangaby monkeys, antibodies to ceramide, galactocerebroside and gangliosides have been shown to be increased 15 months prior to clinical evidence of nerve damage. 9 In a more recent study Vemuri et al. 10 have detected antibodies to all categories of leprosy patients, with anticerarnide antibodies showing higher titres. A specific nerve tissue protein S-100 protein, (so called because of its solubility in 100% saturation with ammonium sulphate) has been demonstrated in normal nerves and nerve complexes by immunoperoxidase staining.
II Employing the same technique the depletion of S-100 protein in dermal nerves of leprosy patients was shown, suggesting the usefulness of this technique in assessing the presence of nerve damage. 1 2 -14 In the present study we have estimated levels of S-1 00 and levels of anticerarnide antibodies in the sera of leprosy patients by ELISA.
Materials and methods

SUBJECTS
Blood samples were collected from untreated leprosy patients, attending the Skin and VD Outpatient Department of Kasturba Hospital, Sevagram. The patients were classified according to the Ridley-Jopling criteria as indeterminate (Ind), tuberculoid (IT), borderline tuberculoid (BT), borderline lepromatous (BL), lepromatous (LL) cases. Blood samples were also collected from healthy subjects living in this region to be used as negative controls. Sera were separated and stored at -70°C with 0.01 % sodium azide as a preservative.
SERUM SAMPLES
A total of 92 serum samples belonging to different groups, namely, Ind (7), IT (18) , BT (17), BL (6), LL (24) and EN (20) were analysed for the presence of S-100 protein.
In addition to the above sera, 68 serum samples of which Ind (1), IT (7), BT (12), BL (17), LL (26) and EN (5) were also screened for anticeramide antibodies. Hence, a total of 160 samples were screened for anticeramide antibodies.
ANTIGENS AND ANTIBODIES
S-100a protein (Sigma Chemical Company, USA) and rabbit anti-S-100 protein antibodies (Dako, Denmark) were provided by Lepra, UK. Cerami de (Centre for Biochemical Technol ogy, New Delhi) and antihuman IgM horse radish peroxidase (HRPO) conjugate (Sigma Chemical Co. USA) and antirabbit IgG HRPO conjugate (Cappel, USA) were used in this study.
INHIBITION ELISA FOR DETERMINATION OF S-IOO PROTEIN
For the detection of S-100 protein, each serum was saturated 50% with ammonium sulphate and centrifuged. The supernatant was collected and added to EDT A at a final concentration of 1 IllM , and then preincubated with 500 ng of rabbit anti-S-100 protein antibodies at 37°C for 30 min and then used for screening by ELISA.
Flat-bottomed PVC microti1re plates (Dynatech, USA) were sensitized with S-100 protein (0· 1 J.l.g/50 J.l.lIwell) in a 0·06 M carbonate buffer pH 9·6 (37°C for 2 hr). The wells were further blocked with 3% bovine serum albumin 100 J.l.lIwell in the same buffer (37°C for 2 hr) and washed 5 times with phosphate buffer saline (0·01 M pH 7·2) containing Tween 20 0·01 % (PBSIT). Then 50 J.l.1 of preincubated reaction mixture of sera were added to the wells (as described above), and incubated at 37°C for 1 hr. After washing with PBSIT the wells were further incubated with optimally diluted (1 : 8000) antirabbit IgG HRPO conjugate at 37°C for 1 hr. Following, the final washing, the immune reaction was revealed by incubating with orthophenylene diarnine (OPD) substrate consisting of 5 mg OPD, 5 rnl citrate phosphate buffer pH 5·0, and 5 J.l.1 of 30% H 2 0 2 . The enzyme substrate reaction was then terminated by addition of 2N HCI 50 J.l.lIwell and the absorbance was read at 490 nm using ELISA reader (Dynatech, MR-250 USA). The optical density values were interpreted in a dose response curve to obtain S-100 protein level in ng/rnl. The dose response curve was prepared by using varying concentrations (0·4 to 2·5 ng/rnl) of S-100 protein in pooled normal serum.
DETECTION OF ANTICERAMIDE IgM ANTIBODY
Indirect ELISA was performed as described by Vemuri et al.
7 Briefly, PVC micro titre plates were coated with ceramide in methanol (2 J.l.g/ml) overnight until completely evaporated and blocked with 3% BSA in phosphate buffered saline (PBS 0·01 MpH 7·2) at 37°C for 2 hr. After 2 washes with PBS, the plates were incubated with sera (1 : 100 in PBS/2·5% NRS) at 37° for 2 hr. After 3 washes with PB S the plate was incubated with antihuman IgM HRPO (1 : 2500) at 37°C for 2 hr. This was followed by 3 washes in PBS. The immune reaction was observed by incubating the wells with OPD substrate and the results evaluated after blocking the reaction using 2N HCI at 490 nm.
STATISTICAL ANALYSIS
Student's t test was used to compare the means of the results obtained in various groups of sera.
Results
The nerve marker S-1 00 protein content has been estimated in a total of 92 sera by inhibition ELISA. Figure 1 shows the calibration curve obtained using pooled normal serum quenched with standard S-100 protein (0-4 to 2·5 ng/ml). The mean S-100 protein levels as summarized in Figure 2 in different groups of leprosy sera ranged between 0· 19 to 0-45 ng/ml compared to that of normal sera (0·07 ng/rnl) and the difference was significant (p < 0·005).
Considering the mean ± SD of S-100 protein levels in normal group as threshold value for positive reaction 5 of 7 indeterminate cases, 16 of 18 IT cases, 13 of 17 BT cases, 6 of 6 BL cases and 23 of 24 LL cases showed the presence of S-100 protein (Figure 3) .
Optical density at 490nm The results of analysis of sera samples for anticerarnide IgM antibodies have been summarized in Figures 4 and 5 . The mean OD values of anticerarnide antibodies in different groups of leprosy sera varied between 0· 141 and 0·275 compared with that of normal 0·063 and the difference was highly significant (p < 0·0005).
By considering the mean ± 2 SD of optical density shown by normal sera as threshold S100 LEVELS (nglml) 
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Discussion
Leprosy being essentially a disease of the peripheral nerves, leads to nerve damage of varying extents in virtually all leprosy patients. Having no definite information on the exact cause of pathogenesis, the autoimmune response against nerve antigen is believed to be one of the possible events leading to nerve damage. The assay of S-lOO protein as well as the anticerarnide IgM antibody have been assessed as to how well they detect nerve damage in leprosy patients.
The results of the present study for anticeramide antibodies showed 37 ·5% indeterminate cases, 28% TT, 66% BT, 78% BL and 62% LL positive. The sera of borderline cases had higher levels of anticerarnide antibodies (Mean ± 2 SD; OD 0·222 ± 0·220) compared to the levels in tuberculoid group (p = <0· 15). In a recent study anticeramide and antigalacto cerebroside antibodies were found in sera of all categories of leprosy patients. Further, anticeramide antibody titres were found to be higher compared to the titres of antigalacto cerebroside antibodies. 1O Analysis of the sera for S-100 antigen detection shows that while only 5% of normals had higher S-lOO protein, as many as 87·5% of different groups of leprosy patients show higher levels ( Figure 2 ). Since S-lOO protein is shown to be specific to nerve tissue 19 higher circulating levels detected in a majority of leprosy patients, possibly indicate progressive destruction of peripheral nerves in these cases. In indeterminate groups 5 of 7 cases had higher levels of S-100 protein. It is possible that these 5 cases are suffering from silent neuritis, and hence had no history qf extensive nerve involvement. Such cases could be rigorously followed for better management. High levels of S-lOO protein were also observed in 83% of borderline cases, possibly as a result of reversal reaction, a common phenomenon seen in this group. S-lOO is a calcium-binding protein believed to be specifically present in the nervous system. However, it has also been shown by immunoperoxidase staining, to be present in various carcinomas of neurogenic and nonneurogenic origin, and also in a limited number of normal cells. It has been speculated that the presence of S-lOO in nonneural cells is due to the origin of these cell types from a common ancestor and migrate to different tissues during embryogenesis Y Depletion of S-lOO protein in peripheral nerves in a tuberculoid granuloma, were studied by immunoperoxidase staining. 12 , 14 Further, Job et al. 13 also showed the usefulness of S-lOO staining to aid in histopathological diagnosis of tuberculoid leprosy lesions, and concluded that S-lOO staining is a useful marker.
